日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Simultaneous Use of Continuous Glucose Monitoring (CGM) Systems and the Remote Electrical Neuromodulation (REN) Wearable for Patients with Comorbid Diabetes and Migraine: An Interventional Single-Arm Compatibility Study

同时使用连续血糖监测(CGM)系统和远程电神经调节(REN)可穿戴设备治疗合并糖尿病和偏头痛患者:一项单组干预性兼容性研究

Asmar, Yara; Stark-Inbar, Alit; Wilson, Maria Carmen; Podraza, Katherine; Treppendahl, Christina; Demirci, Cem; deMayo, Richelle

Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials

Ubrogepant 用于急性偏头痛治疗:来自 ACHIEVE I 和 ACHIEVE II 3 期随机试验的汇总疗效、安全性和耐受性

Hutchinson, Susan; Dodick, David W; Treppendahl, Christina; Bennett, Nathan L; Yu, Sung Yun; Guo, Hua; Trugman, Joel M

Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers

人类内源性逆转录病毒在血液系统癌症中形成 T 细胞靶点库

Sunil Kumar Saini, Andreas Due Ørskov, Anne-Mette Bjerregaard, Ashwin Unnikrishnan, Staffan Holmberg-Thydén, Annie Borch, Kathrine Valentini Jensen, Govardhan Anande, Amalie Kai Bentzen, Andrea Marion Marquard, Tripti Tamhane, Marianne Bach Treppendahl, Anne Ortved Gang, Inge Høgh Dufva, Zoltan Szal

Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk

司美格鲁肽(SUSTAIN 和 PIONEER)可降低不同心血管风险的 2 型糖尿病患者的心血管事件发生率。

Husain, Mansoor; Bain, Stephen C; Jeppesen, Ole K; Lingvay, Ildiko; Sørrig, Rasmus; Treppendahl, Marianne B; Vilsbøll, Tina

Trial design and baseline data for LIRA-PRIME: A randomized trial investigating the efficacy of liraglutide in controlling glycaemia in type 2 diabetes in a primary care setting

LIRA-PRIME试验设计和基线数据:一项在基层医疗机构中研究利拉鲁肽控制2型糖尿病患者血糖疗效的随机试验

Unger, Jeff; Allison, Dale C; Carlton, Melissa; Lakkole, Kavitha; Lowe, Derek; Murphy, Gerri; Panda, Jayant K; Sargin, Mehmet; Kaltoft, Margit; Treppendahl, Marianne B; Zoghbi, Marouan

Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial

LEADER试验中,接受利拉鲁肽治疗与接受安慰剂治疗的发生心肌梗死患者的心血管结局

Nauck, Michael A; Tornøe, Karen; Rasmussen, Søren; Treppendahl, Marianne Bach; Marso, Steven P

Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations

肿瘤抑制性microRNA在伴有剪接体突变的骨髓增生异常综合征中表达下调

Aslan, Derya; Garde, Christian; Nygaard, Mette Katrine; Helbo, Alexandra Søgaard; Dimopoulos, Konstantinos; Hansen, Jakob Werner; Severinsen, Marianne Tang; Treppendahl, Marianne Bach; Sjø, Lene Dissing; Grønbæk, Kirsten; Kristensen, Lasse Sommer

Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation

氮胞苷对 MDS/AML 患者 T 细胞中 PD-1 的低甲基化和上调作用:联合靶向 PD-1 和 DNA 甲基化的理论基础

Andreas D Ørskov, Marianne B Treppendahl, Anni Skovbo, Mette S Holm, Lone S Friis, Marianne Hokland, Kirsten Grønbæk

5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies

5-氮杂胞苷治疗可增强肿瘤细胞对T细胞介导的细胞毒性的敏感性,并调节髓系恶性肿瘤患者的NK细胞。

Gang, A O; Frøsig, T M; Brimnes, M K; Lyngaa, R; Treppendahl, M B; Grønbæk, K; Dufva, I H; Straten, P Thor; Hadrup, S R

Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?

弥漫大 B 细胞淋巴瘤伴有 TP53 突变和 MIR34A 甲基化:另一种预后极差的“双重打击”淋巴瘤?

Fazila Asmar, Christoffer Hother, Gorjan Kulosman, Marianne Bach Treppendahl, Helene Myrtue Nielsen, Ulrik Ralfkiaer, Anja Pedersen, Michael Boe Møller, Elisabeth Ralfkiaer, Peter de Nully Brown, Kirsten Grønbæk